These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15928921)

  • 1. Comparative analysis of different competitive antagonists interaction with NR2A and NR2B subunits of N-methyl-D-aspartate (NMDA) ionotropic glutamate receptor.
    Blaise MC; Sowdhamini R; Pradhan N
    J Mol Model; 2005 Nov; 11(6):489-502. PubMed ID: 15928921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolutionary trace analysis of ionotropic glutamate receptor sequences and modeling the interactions of agonists with different NMDA receptor subunits.
    Blaise MC; Sowdhamini R; Rao MR; Pradhan N
    J Mol Model; 2004 Dec; 10(5-6):305-16. PubMed ID: 15597199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Native N-methyl-D-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites.
    Christie JM; Jane DE; Monaghan DT
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1169-74. PubMed ID: 10688637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition.
    Laurie DJ; Seeburg PH
    Eur J Pharmacol; 1994 Aug; 268(3):335-45. PubMed ID: 7528680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of subunit- and antagonist-specific amino acid residues in the N-Methyl-D-aspartate receptor glutamate-binding pocket.
    Kinarsky L; Feng B; Skifter DA; Morley RM; Sherman S; Jane DE; Monaghan DT
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1066-74. PubMed ID: 15743930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural consequences of D481N/K483Q mutation at glycine binding site of NMDA ionotropic glutamate receptors: a molecular dynamics study.
    Blaise MC; Bhattacharyya D; Sowdhamini R; Pradhan N
    J Biomol Struct Dyn; 2005 Feb; 22(4):399-410. PubMed ID: 15588104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular determinants of ligand discrimination in the glutamate-binding pocket of the NMDA receptor.
    Laube B; Schemm R; Betz H
    Neuropharmacology; 2004 Dec; 47(7):994-1007. PubMed ID: 15555634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
    Frizelle PA; Chen PE; Wyllie DJ
    Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model structures of the N-methyl-D-aspartate receptor subunit NR1 explain the molecular recognition of agonist and antagonist ligands.
    Moretti L; Pentikäinen OT; Settimo L; Johnson MS
    J Struct Biol; 2004 Mar; 145(3):205-15. PubMed ID: 14960371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.
    Bettini E; Sava A; Griffante C; Carignani C; Buson A; Capelli AM; Negri M; Andreetta F; Senar-Sancho SA; Guiral L; Cardullo F
    J Pharmacol Exp Ther; 2010 Dec; 335(3):636-44. PubMed ID: 20810618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors.
    Erreger K; Geballe MT; Kristensen A; Chen PE; Hansen KB; Lee CJ; Yuan H; Le P; Lyuboslavsky PN; Micale N; Jørgensen L; Clausen RP; Wyllie DJ; Snyder JP; Traynelis SF
    Mol Pharmacol; 2007 Oct; 72(4):907-20. PubMed ID: 17622578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delineation of additional PSD-95 binding domains within NMDA receptor NR2 subunits reveals differences between NR2A/PSD-95 and NR2B/PSD-95 association.
    Cousins SL; Kenny AV; Stephenson FA
    Neuroscience; 2009 Jan; 158(1):89-95. PubMed ID: 18308477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stacking-interactions in the control-gear binding of kynurenic acid with NR2A- and GluR2-subunits of glutamate ionotropic receptors].
    Zhuravlev AV; Shchegolev BF; Savvateeva-Popova EV; Popov AV
    Ross Fiziol Zh Im I M Sechenova; 2007 Jun; 93(6):609-24. PubMed ID: 17850019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling.
    Chen PE; Geballe MT; Stansfeld PJ; Johnston AR; Yuan H; Jacob AL; Snyder JP; Traynelis SF; Wyllie DJ
    Mol Pharmacol; 2005 May; 67(5):1470-84. PubMed ID: 15703381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The micromolar zinc-binding domain on the NMDA receptor subunit NR2B.
    Rachline J; Perin-Dureau F; Le Goff A; Neyton J; Paoletti P
    J Neurosci; 2005 Jan; 25(2):308-17. PubMed ID: 15647474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core.
    Furukawa H; Gouaux E
    EMBO J; 2003 Jun; 22(12):2873-85. PubMed ID: 12805203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a three-dimensional model for the N-methyl-D-aspartate NR2A subunit.
    Grazioso G; Moretti L; Scapozza L; De Amici M; De Micheli C
    J Med Chem; 2005 Aug; 48(17):5489-94. PubMed ID: 16107147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
    Priestley T; Laughton P; Myers J; Le Bourdellés B; Kerby J; Whiting PJ
    Mol Pharmacol; 1995 Nov; 48(5):841-8. PubMed ID: 7476914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and pharmacological characterization of recombinant rat/mice N-methyl-D-aspartate receptor subtypes in the yeast Saccharomyces cerevisiae.
    Becker J; Li Z; Noe CR
    Eur J Biochem; 1998 Sep; 256(2):427-35. PubMed ID: 9760184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological and genetic evidence indicates that combined inhibition of NR2A and NR2B subunit containing NMDA receptors is required to disrupt prepulse inhibition.
    Spooren W; Mombereau C; Maco M; Gill R; Kemp JA; Ozmen L; Nakanishi S; Higgins GA
    Psychopharmacology (Berl); 2004 Aug; 175(1):99-105. PubMed ID: 14985927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.